Open AccessCYP19A1 gene expression in patients with polycystic ovarian syndrome
Author(s) -
Roselina Panghiyangani,
Purnomo Soeharso,
Andrijono,
Dwi Anita Suryandari,
Budi Wiweko,
Mala Kurniati,
Dwi Ari Pujianto
Publication year - 2020
Publication title -
journal of human reproductive sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.484
H-Index - 31
eISSN - 0974-1208
pISSN - 1998-4766
DOI - 10.4103/jhrs.jhrs_142_18
Subject(s) - aromatase , anovulation , hyperandrogenism , polycystic ovary , medicine , endocrinology , ovulation induction , infertility , luteinizing hormone , testosterone (patch) , androgen , hormone , biology , ovulation , insulin , insulin resistance , pregnancy , breast cancer , cancer , genetics
Polycystic ovarian syndrome (PCOS) is a common endocrine system disorder among the women of reproductive age, yet the etiology of PCOS remains unclear. Infertility in females with PCOS can be caused by anovulation, high luteinizing hormone levels, and hyperandrogenism.